Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$57.23
$3.07(4.40%)
At close: 4:00 PM EDT
$57.23
$3.07(4.40%)
Day’s Range― - ―
52-Week Range$29.01 - $73.75
Previous CloseN/A
Volume2.48M
Average Volume (3M)2.39M
Market Cap
$12.04B
Enterprise Value$17.21B
Total Cash (Recent Filing)$550.38M
Total Debt (Recent Filing)$2.39B
Price to Earnings (P/E)42.6
Beta1.18
Next Earnings
Oct 30, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.43
Shares Outstanding197,864,240
10 Day Avg. Volume2,171,740
30 Day Avg. Volume2,392,302
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue1.20
Enterprise Value/Gross Profit9.67
Enterprise Value/Ebitda26.94
Forecast
1Y Price Target
$80.54Price Target Upside40.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)1.82
Revenue Forecast (FY)$15.34B
Bulls Say, Bears Say
Bulls Say
Growth OutlookThe reiterated outlook indicates broad-based growth across Pharmacy Solutions and Provider Services, with adjusted EBITDA expected to grow faster than revenue. If achieved, this trajectory would expand earnings capacity and provide resources for continued investment, integration, and debt reduction.
Cash Generation And LeverageStrong trailing cash generation and materially improved leverage strengthen BrightSpring’s financial flexibility. Management’s plan to reduce leverage further while generating approximately $600 million of 2026 operating cash flow could support acquisition activity, investment, and greater resilience.
Care Quality And Operating ScaleConsistently strong quality and service metrics across home health, pharmacy, and specialty care indicate effective operating execution in complex patient populations. Maintaining these standards can reinforce provider credibility and support scalable growth across BrightSpring’s integrated care platform.
Bears Say
Thin And Declining MarginsProfitability has recovered, but the low EBITDA margin leaves limited room for execution errors or reimbursement pressure. The longer-term gross-margin decline also signals persistent cost intensity, which could constrain earnings conversion even as revenue continues to expand.
IRA Pricing HeadwindIRA-related pricing changes create a structural reimbursement headwind for Home & Community Pharmacy rather than a transient volume fluctuation. The expected revenue reduction and roughly $15 million EBITDA impact may weigh on segment economics and require ongoing cost and mix management.
Early-Stage Chronic InfusionAlthough chronic infusion is growing, management’s assessment shows the business remains underpenetrated and requires continued commercial, technology, and leadership investment. This increases execution demands and delays the point at which the platform can contribute its targeted scale and profitability.
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $29.01 and its highest was $73.75 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $12.04B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Oct 30, 2026 which is in 12 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Jul 31, 2026. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.396 by $0.054.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.47.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 197,864,240 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.45 in its last earnings report, beating expectations of $0.396. Following the earnings report the stock price went down -18.071%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$80.54 (40.73% Upside)
$80.54 (40.73% Upside)
Blogger Sentiment
Neutral
BTSG Sentiment 58%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
106.68%
12-Months-Change
Fundamentals
Return on Equity
15.23%
Trailing 12-Months
Asset Growth
0.71%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated broad-based, above-expectation operational and financial execution: strong top-line growth (23% YoY), robust adjusted EBITDA growth (44% YoY), margin expansion, quality and patient satisfaction leadership, balance sheet progress and constructive guidance. Notable headwinds were clearly disclosed—primarily IRA-driven revenue impacts to Home & Community Pharmacy, a one-time tax cash outflow that depressed reported OCF in the quarter, some sequential margin seasonality, and an earlier-stage chronic infusion ramp. On balance the positive growth, margin improvement, quality metrics, cash generation guidance and credit upgrades outweigh the disclosed challenges.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$80.54
▲(40.73% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Evolent Health
―
Teladoc
―
Privia Health Group
―
Hinge Health, Inc. Class A
―
Omada Health, Inc.
―
Ownership Overview
28.15% Insiders
31.44% Mutual Funds
0.15% Other Institutional Investors
17.86% Public Companies and Individual Investors











